Companies
Benchling
BenchlingSan Francisco, CA
Founded 2012
Healthcare Technology Systems
Last Round Valuation
$6.1B
Last Round Share Price
$ XX.XY
Total Funding
$417M
Last Round
Series F
Funding Rounds
Nothing here |
Information contained herein is based on estimates and is subject to update.
News
06/11/2025
Benchling Partners with Merck to Enhance Bioanalytical Workflows
Benchling's collaboration with Merck signifies a strategic move to streamline bioanalytical processes, potentially accelerating drug development timelines and enhancing competitive positioning in the biopharmaceutical sector.
05/07/2025
Moderna and Benchling Expand Collaboration to Enhance R&D Digital Infrastructure
Moderna's collaboration with Benchling to enhance R&D digital infrastructure signals a strategic shift towards more efficient drug development processes, potentially accelerating innovation and reducing time-to-market for new therapies.
01/22/2025
Benchling to Host Free Webinar on AI in Antibody Discovery
Benchling's free webinar on AI in antibody discovery highlights the growing intersection of technology and biotechnology, potentially accelerating innovation and collaboration in drug development while democratizing access to advanced research tools.
Research
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How can I get notified when there are new interested buyers of my shares?
Are orders posted anonymously?
How do Augment fees work?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.